Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2017.7414 mmr-16-05-6512 Articles Taurine alleviates lipopolysaccharide-induced liver injury by anti-inflammation and antioxidants in rats LiuYueyan 1 LiFeng 1 ZhangLi 2 WuJianfeng 1 WangYanmei 2 YuHong 1 Department of Physiology, School of Clinical Medicine, West Anhui Health Vocational College, Lu'an, Anhui 237005, P.R. China Department of Anatomy, School of Clinical Medicine, West Anhui Health Vocational College, Lu'an, Anhui 237005, P.R. China Correspondence to: Professor Yueyan Liu, Department of Physiology, School of Clinical Medicine, West Anhui Health Vocational College, 9 Gaocheng Road, Lu'an, Anhui 237005, P.R. China, E-mail: liuyueyan_0726@163.com 052017 31082017 16 5 6512 6517 26052016 20042017 Copyright: © Liu et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

The aim of the present study was to investigate the protective effect of taurine on lipopolysaccharide (LPS)-induced liver injury and its mechanisms. Male rats were randomly divided into three groups: Normal saline, LPS model and taurine treatment. Experimental animals were treated with saline or taurine (dissolved in saline, 200 mg/kg/day) via intravenous injection. After 2 h, saline or LPS (0.5 mg/kg) was administrated via intraperitoneal injection. Markers of liver injury, pro-inflammatory cytokines and superoxide dismutase (SOD) activity were determined in plasma. Liver tissues were removed for morphological analysis and determination by western blot analysis. Taurine significantly reduced the elevation in the levels of LPS-induced aspartate transaminase and alanine transaminase and decreased the concentrations of LPS-induced inflammatory factors including tumor necrosis factor-α and interleukin-6. Taurine also increased the activity of SOD in serum and the expression of heme oxygenase-1 protein in liver tissue. Taurine pretreatment also reduced the elevated expression levels of LPS-induced cyclooxygenase-2, nuclear factor κB and extracellular regulated protein kinase. The results from the present study demonstrated that taurine alleviates LPS-induced liver injury. The beneficial role of taurine may be associated with its reduction of pro-inflammatory response and oxidative stress.

 taurine lipopolysaccharide liver injury Introduction

Hepatic disorder has become a major disease endangering human health and exhibits a high morbidity and fatality rate (1). As the mechanisms of severe hepatic failure are poorly understood, there remains a lack of effective treatment. An increasing number of studies have suggested that the production of inflammatory cytokines serves important roles in various types of liver damage (2,3). Lipopolysaccharide (LPS), a component of Gram-negative bacteria, can activate liver macrophages, which produce inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β and IL-6 (4–6). In addition, LPS possesses pro-oxidative action via the induction of excessive production of reactive oxygen species (ROS). ROS are the major cause of damage to macromolecules, including protein and DNA, and to the cell membrane, which leads to mitochondrial dysfunction (7,8). A further study demonstrated that ROS are involved in modulation of the inflammatory response (9). Various types of liver damage, including ischemia-reperfusion and liver cancer, are associated with LPS (10,11). Therefore, LPS-induced liver injury is used as an animal model of liver disorder.

Taurine, a sulfur-containing β-amino acid, is a metabolic product of L-cysteine and is abundant in a number of mammalian tissues. Taurine is not involved in the synthesis of protein; however, considerable evidence has demonstrated that taurine serves a number of vital roles in physiological processes, including regulation of calcium concentration (12), stabilization of the cell membrane (13), regulation of blood pressure and protection of endothelial cells (14). The antioxidant properties of taurine have been confirmed by a number of results, although taurine itself is not able to scavenge ROS. Taurine exerts its antioxidant action by inhibiting the production of ROS, which result from the increasing activities of antioxidases (15). Certain studies have indicated that taurine protects cells against oxidative stress (16,17). Taurine is changed into taurine chloramine (TauCl) in vivo, which inhibits secretion of pro-inflammatory cytokines including IL-6, IL-1β, TNF-α and IL-8 (18,19). It is suggested that taurine is a potent anti-inflammatory factor.

The present study examined the beneficial effects of taurine on LPS-induced liver injury in rats. The results suggested that administration of taurine may be beneficial for patients with hepatopathy.

 Materials and methods <sec> <title>Animals and experimental design

A total of 30 healthy male Sprague-Dawley rats (weighing 280±20 g) were obtained from the Animal Center at West Anhui Health Vocational College and housed in a standard facility at 22°C and 50–70% humidity with a 12-h light/dark cycle. Experimental rats received a standard pellet diet and water ad libitum. The study was approved by the Ethics Committee of West Anhui Health Vocational College (Lu'an, China). After a week, the animals were randomly divided into three groups (n=10 per group): i) Normal saline group (NS), ii) LPS control group (LPS) and iii) taurine + LPS group (TL). Rats from NS and LPS were treated with sterile saline by intravenous injection and animals from TL were intravenously injected with taurine (100 mg/kg body weight, dissolved in sterile saline; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). After 4 h, rats from LPS and TL groups were intraperitoneally injected with LPS (10 mg/kg body weight, dissolved in sterile saline; Sigma-Aldrich; Merck KGaA) and NS rats received sterile saline. At 6 h following administration of LPS, the animals were anesthetized with sodium pentobarbital (50 mg/kg, i.p.; Sigma-Aldrich; Merck KGaA) to collect blood samples prior to animal sacrifice. Fasting blood samples were collected by artery catheterization for biochemical analyses and liver tissues were obtained for histological analyses.

 Determination of liver function

Fasting blood samples were centrifuged at 3,000 × g to separate the serum. Markers of liver function, serum aspartate transaminase (AST) and alanine transaminase (ALT) were determined using an enzymatic colorimetric method (Diagnostica Stago S.A.S., Paris, France) according to the manufacturer's protocols and analyzed by a semi-automatic analyzer, with the results being expressed as U/l.

 Measurement of inflammatory cytokines

Serum levels of TNF-α, procalcitonin (PCT) and IL-6 were detected with rat TNF-α (cat. no. ELS-2855-1), PCT (cat. no. ELS-3485-1) and IL-6 (cat. no. ELS-2866-1) specific ELISA kits (Hefei Bomei Biotechnology Co., Ltd., Hefei, China) according to manufacturer's protocol. The levels of TNF-α and IL-6 were expressed as ng/l.

 Estimation of antioxidant effects

To estimate changes in antioxidant effects, the activity of the antioxidase, superoxide dismutase (SOD) was determined using xanthine oxidase methods, and the content of lipid peroxidation production, malonaldehyde (MDA), was measured using thiobarbituric acid methods, according to the manufacturer's protocol (both from Nanjing Jiancheng Bioengineering Institute, Nanjing, China).

 Histological analysis

Liver tissues were harvested and fixed in 4% phosphate-buffered formalin for pathological analysis. Fixed tissues were dehydrated in ethanol, embedded in paraffin and 5 µm sections were cut. After drying overnight, sections were dewaxed, rehydrated and stained with hematoxylin and eosin (H&E) for histomorphological observation under a light microscope.

 Western blot analysis

Liver tissues (0.2 g) were harvested, lysed and homogenized in 2 ml lysis buffer with 10 mM Tris-buffered saline, 1 mM EDTA, 1 mM EGTA, 2 mM PMSF and 1% Triton X-100 (v/v) for 20 min. Lysates were centrifuged at 13,000 × g for 15 min at 4°C. Protein concentration was measured using a Quick Start™ Bradford protein assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Denatured proteins in supernatants were separated by 10% SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were blocked with 5% non-fat milk in TBS with Tween-20 (10 mM Tris-HCl, 150 mM NaCl and 1% Tween-20) for 2 h. The membranes were subsequently incubated with primary polyclonal antibodies against β-actin (1:1,000), heme oxygenase-1 (HO-1; 1:1,000), cyclooxygenase-2 (COX-2), nuclear factor (NF)-κB, phosphorylated (p)-NF-κB, extracellular signal-regulated kinase (ERK) and p-ERK1/2 (Bio Basic Inc., Markham, ON, Canada) overnight at 4°C. Following an extensive wash with TBST, the membranes were incubated with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10,000; cat. no. A9169; Sigma-Aldrich; Merck KGaA) for 2 h at room temperature. The membranes were washed three times and visualized with 3,3′-diaminobenzidine (Bio Basic Inc.).

 Statistical analysis

All values are expressed as mean ± standard deviation. The data were analyzed using SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA). Statistical difference was determined by Tukey's test for unpaired data or one-way analysis of variance with least significant difference-t and/or Tamhane's T2 post hoc tests for multiple comparisons. P<0.05 was considered statistically to indicate a statistically significant difference.

 Results <sec> <title>Ameliorative effects of taurine on liver damage

To examine liver function, serum AST and ALT transaminases were determined. The result demonstrated a significant increase in activity of AST and ALT in LPS rats compared with NS rats (P<0.01; Fig. 1). Administration of taurine reduced the increase in activity of AST and ALT (P<0.01; Fig. 1).

 Change of antioxidant effects

The activity of serum SOD, an antioxidase, was reduced and the content of serum MDA, a product of lipid peroxidation, was increased in LPS-treated rats compared with NS rats (P<0.01; Fig. 2). Taurine significantly enhanced SOD activity and decreased the concentration of MDA (P<0.01; Fig. 2).

 Effects of taurine on pro-inflammatory cytokines

The levels of TNF-α and IL-6 in serum were significantly increased in LPS rats (P<0.01; Fig. 3A and B) and an increased level of PCT was determined (P<0.05; Fig. 3C). Taurine treatment prior to LPS significantly reduced the levels of TNF-α and IL-6 (P<0.01; Fig. 3A and B) and decreased the concentration of PCT (P<0.05; Fig. 3C).

 Effects of taurine on hepatic histopathology

Liver sections stained with H&E were observed under a light microscope for hepatic morphology. Recruitment of inflammatory cells and release of inflammatory factors in liver are involved in liver injury (20). Exposure to LPS resulted in an increase in the infiltration of inflammatory cells and hepatocyte edema (Fig. 4). Administration of taurine prior to LPS attenuated congestion in liver tissues, abated the number of the infiltration of inflammatory cells and intact lobular structure was observed (Fig. 4).

 Effects of taurine on liver ERK1/2, COX-2, HO-1 and NF-κB protein expression

Antioxidant alterations were examined; taurine pretreatment elevated HO-1 protein expression (Fig. 5A). Furthermore, the protein expression levels of COX-2 (Fig. 5B), NF-κB (Fig. 5C) and p-ERK (Fig. 5D) were investigated to evaluate inflammation signaling. Taurine pretreatment reduced the protein expression of NF-κB, COX-2 and p-ERK.

 Discussion

It is well-known that activation of macrophages and release of inflammatory cytokines serve important roles in organ damage, including acute and chronic liver injury (21,22). The present study aimed to investigate effects of taurine pretreatment on LPS-induced liver injury. The results demonstrated that taurine pretreatment by intravenous injection reduced the activity of plasma AST and ALT, and decreased the level of serum inflammatory cytokines including TNF-α, IL-6 and MDA. Serum SOD activity and HO-1 protein expression in liver was significantly increased in taurine-pretreated rats, while COX-2, pNF-κB (E) and p-ERK protein expression levels in liver were reduced. In addition, taurine pretreatment alleviated the infiltration of inflammatory cells in liver tissues and hepatic congestion. The present study suggested that taurine pretreatment protected the liver against LPS-induced injury.

LPS-induced tissue injury results from an increase in the release of cytokines, oxidative stress and impairment of mitochondrial function (23). LPS induces excessive release of pro-inflammatory cytokines including TNF-α and IL-6 and the production of ROS by binding with Toll-like receptor 4 on the surface of Küpffer cells (24,25), stimulating the apoptosis of hepatic cells and necrosis (26).

Oxidative stress results from excessive generation of ROS and/or deletion of antioxidants including reduced activities of the antioxidant enzymes, imbalance of glutathione redox status (27) and increased products of lipid peroxidation (28), which damages cells via macromolecules and mitochondrial dysfunction, further harming various tissues including the liver (7,29). Release of ROS is a mechanism of LPS-induced hepatic injury, therefore reduction of ROS signaling relieves such damage (30). Studies have indicated that treatment with antioxidant and anti-inflammatory agents is beneficial in LPS-induced hepatic injury (31,32), and that taurine can reduce oxidative stress (33,34) and relieve tissue injuries by its antioxidative properties (35,36). The results of the present study indicated that administration of LPS resulted increased ALT and AST activities in serum, considered as markers of liver injury. Taurine pretreatment reduced the increases of ALT and AST, and decreased the concentration of MDA, a marker of lipid peroxidation; it also elevated the activity of SOD and the protein expression of antioxidant enzyme HO-1.

Inflammatory response serves an important role in various liver disorders. LPS initiates inflammation by recruiting neutrophils to the liver and subsequently stimulating the expression of inflammatory factors, including TNF-α, which provoke the release of ROS (37). The results of the present study demonstrated that LPS elevated the levels of TNF-α and IL-6 in serum and expression of COX-2 and NF-κB protein. Taurine pretreatment reduced the expression of pro-inflammatory proteins including COX-2 and NF-κB.

It is reported that taurine is converted into taurine chloramine in vivo and that this reduces the inflammatory response (38). Taurine increases its antioxidative effects by increasing the expression of HO-1 protein (39), which is reported to inhibit expression of COX-2 (40). COX-2 induces the production of prostaglandin, which is involved in inflammation and pain and results in cellular injury (41,42). HO-1, an inducible rate-limiting enzyme, catalyzes heme into equimolar amounts of carbon monoxide (CO), biliverdin and free iron. Induction of HO-1 may protect against oxidative stress-related cell and tissue injury (40,43). Biliverdin has been confirmed to be a potent antioxidant (44). CO, a catalytic product of HO-1, exerts antioxidative, anti-inflammatory and anti-apoptotic effects (45). Increasing evidence has confirmed that the HO/CO signaling exerts a vital role in regulation of anti-inflammation and cytoprotection (46–48).

NF-κB is involved in LPS signaling. Activation of NF-κB by LPS upregulates the expression of COX-2 (49). It is reported that the anti-inflammatory effect of CO is associated with its regulation on transcription factors including NF-κB (50,51). A previous study demonstrated that CO alleviates LPS-induced inflammation by suppression of NF-κB (48). The results suggested that taurine inhibited NF-κB/COX-2 signaling via induction of HO-1. In addition, the mitogen-activated protein kinase (MAPK)/ERK pathway is implicated in LPS-induced inflammation (52) and is an upstream mediator of NF-κB nuclear translocation (53,54). Another study demonstrated that reduced MAPK/ERK1/2 signaling downregulates NF-κB in LPS-activated hepatocytes (54). Recent studies have indicated that increased levels of phosphorylated ERK and c-Jun N-terminal kinases promote COX-2 protein expression (55,56).

In conclusion, the results of the present study indicated that taurine pretreatment protected the liver against LPS-induced injury by increasing its antioxidation and anti-inflammation ability, which were associated with the increased expression of HO-1 protein and reduced expression levels of NF-κB, COX-2 and p-ERK proteins. The findings suggested that taurine reduced NF-κB/COX-2 signaling by activation of HO-1/CO.

 Acknowledgements

The present study was supported by the Outstanding Young Talent Fund Key Project of Anhui Province (grant no. 2013SQRL146ZD).

 References MizuharaHO'NeillESekiNOgawaTKusunokiCOtsukaKSatohSNiwaMSenohHFujiwaraHT cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6J Exp Med17915291537199410.1084/jem.179.5.152981639362191474 GaspariniCFeldmannMNF-κB as a target for modulating inflammatory responsesCurr Pharm Des1857355745201210.2174/13816121280353076322726116 JosephsMDBahjatFRFukuzukaKKsontiniRSolorzanoCCEdwardsCKIIITannahillCLMacKaySLCopelandEMIIIMoldawerLLLipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligandAm J Physiol Regul Integr Comp Physiol278R1196R1201200010801287 EnomotoNIkejimaKBradfordBURiveraCAKonoHGotoMYamashinaSSchemmerPKitamuraTOideHRole of Kupffer cells and gut-derived endotoxins in alcoholic liver injuryJ Gastroenterol Hepatol15SupplD20D25200010.1046/j.1440-1746.2000.02179.x10759216 UesugiTFrohMArteelGEBradfordBUWheelerMDGäbeleEIsayamaFThurmanRGRole of lipopolysaccharide-binding protein in early alcohol-induced liver injury in miceJ Immunol16829632969200210.4049/jimmunol.168.6.296311884468 EnomotoNSchemmerPIkejimaKTakeiYSatoNBrennerDAThurmanRGLong-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharideAlcohol Clin Exp Res2513601367200110.1111/j.1530-0277.2001.tb02359.x11584157 CadenasSCadenasAMFighting the stranger-antioxidant protection against endotoxin toxicityToxicology1804563200210.1016/S0300-483X(02)00381-512324199 MallisRJBussJEThomasJAOxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteinesBiochem J355145153200110.1042/bj3550145112569591221722 ZuoYXiangBYangJSunXWangYCangHYiJOxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1Cell Res19449457200910.1038/cr.2009.1919238172 CollettiLMGreenMLung and liver injury following hepatic ischemia/reperfusion in the rat is increased by exogenous lipopolysaccharide which also increases hepatic TNF production in vivo and in vitroShock16312319200110.1097/00024382-200116040-0001411580116 YuLXYanHXLiuQYangWWuHPDongWTangLLinYHeYQZouSSEndotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodentsHepatology5213221333201010.1002/hep.2384520803560 HuxtableRJPhysiological actions of taurinePhysiol Rev7210116319921731369 Pasantes-MoralesHWrightCEGaullGETaurine protection of lymphoblastoid cells from iron-ascorbate induced damageBiochem Pharmacol3422052207198510.1016/0006-2952(85)90419-84004939 MaiaARBatistaTMVictorioJAClericiSPDelbinMACarneiroEMDavelAPTaurine supplementation reduces blood pressure and prevents endothelial dysfunction and oxidative stress in post-weaning protein-restricted ratsPLoS One9e105851201410.1371/journal.pone.0105851251708954149434 Sun JangJPiaoSChaYNKimCTaurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxideJ Clin Biochem Nutr453743200910.3164/jcbn.08-262195907052704325 SchafferSWAzumaJMozaffariMRole of antioxidant activity of taurine in diabetesCan J Physiol Pharmacol879199200910.1139/Y08-11019234572 ErdamarHTurközkanNEkremoğluMKurtYYamanHThe effect of taurine on polymorphonuclear leukocyte functions in endotoxemiaAmino Acids33581585200710.1007/s00726-007-0543-y17520328 KontnyEPlebanczykMLisowskaBOlszewskaMMaldykPMaslinskiWComparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: Contribution to adipocytokine networkAnn Rheum Dis71262267201210.1136/annrheumdis-2011-20012321989538 MarcinkiewiczJKontnyETaurine and inflammatory diseasesAmino Acids46720201410.1007/s00726-012-1361-422810731 AmbadeACatalanoDLimAMandrekarPInhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in miceHepatology5515851595201210.1002/hep.24802221057793342823 RossignolDPLynnMTLR4 antagonists for endotoxemia and beyondCurr Opin Investig Drugs6496502200515912963 NolanJPThe role of intestinal endotoxin in liver injury: A long and evolving historyHepatology5218291835201010.1002/hep.2391720890945 LowesDAWebsterNRMurphyMPGalleyHFAntioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsisBr J Anaesth110472480201310.1093/bja/aes577233817203570068 SunSZhangHXueBWuYWangJYinZLuoLProtective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in ratsInflamm Res55504510200610.1007/s00011-006-6037-717122969 OhsakiYShirakawaHHiwatashiKFurukawaYMizutaniTKomaiMVitamin K suppresses lipopolysaccharide-induced inflammation in the ratBiosci Biotechnol Biochem70926932200610.1271/bbb.70.92616636460 WangYGaoLNCuiYLJiangHLProtective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in miceEvid Based Complement Alternat Med20141539022014247721783977120 DaviesKJProtein damage and degradation by oxygen radicals. I. General aspectsJ Biol Chem2629895990119873036875 KleinTNeuhausKReutterFNüsingRMGeneration of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanismBr J Pharmacol133643650200110.1038/sj.bjp.0704111114293871572827 SewerynekEMelchiorriDChenLReiterRJMelatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitroFree Radic Biol Med19903909199510.1016/0891-5849(95)00101-38582667 HsingCHLinMCChoiPCHuangWCKaiJITsaiCCChengYLHsiehCYWangCYChangYPAnesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKKβ/NF-κB signalingPLoS One6e17598201110.1371/journal.pone.0017598214081253050912 AjuwonOROguntibejuOOMarnewickJLAmelioration of lipopolysaccharide-induced liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and oxidative stressBMC Complement Altern Med14392201410.1186/1472-6882-14-392253127954201726 TakataJItoSKarubeYNagataYMatsushimaYWater-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicityBiol Pharm Bull20204209199710.1248/bpb.20.2049057988 OliveiraMWMinottoJBde OliveiraMRZanotto-FilhoABehrGARochaRFMoreiraJCKlamtFScavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen speciesPharmacol Rep62185193201010.1016/S1734-1140(10)70256-520360629 JeonSHLeeMYRahmanMMKimSJKimGBParkSYHongCUKimSZKimJSKangHSThe antioxidant, taurine reduced lipopolysaccharide (LPS)-induced generation of ROS, and activation of MAPKs and Bax in cultured pneumocytesPulm Pharmacol Ther22562566200910.1016/j.pupt.2009.07.00419665057 MotawiTKAbd ElgawadHMShahinNNModulation of indomethacin-induced gastric injury by spermine and taurine in ratsJ Biochem Mol Toxicol21280288200710.1002/jbt.2019417912696 ShimizuMZhaoZIshimotoYSatsuHDietary taurine attenuates dextran sulfate sodium (DSS)-induced experimental colitis in miceAdv Exp Med Biol643265271200910.1007/978-0-387-75681-3_2719239157 McDonaldBJenneCNZhuoLKimataKKubesPKupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemiaAm J Physiol Gastrointest Liver Physiol305G797G806201310.1152/ajpgi.00058.201324113769 WeissSJKleinRSlivkaAWeiMChlorination of taurine by human neutrophils. Evidence for hypochlorous acid generationJ Clin Invest70598607198210.1172/JCI1106526286728370261 WangGGLiWLuXHZhaoXXuLTaurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic ratsCroat Med J54171179201310.3325/cmj.2013.54.171236301443641874 ShihRHYangCMInduction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cellsJ Neuroinflammation786201010.1186/1742-2094-7-86211185743002338 FletcherJREicosanoids. Critical agents in the physiological process and cellular injuryArch Surg12811921196199310.1001/archsurg.1993.014202300200038239981 WilliamsJAShacterERegulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and −2J Biol Chem2722569325699199710.1074/jbc.272.41.256939325293 ChenQYWangGGLiWJiangYXLuXHZhouPPHeme oxygenase-1 promotes delayed wound healing in diabetic ratsJ Diabetes Res20169726503201610.1155/2016/972650326798657 StockerRYamamotoYMcDonaghAFGlazerANAmesBNBilirubin is an antioxidant of possible physiological importanceScience23510431046198710.1126/science.30298643029864 RyterSWAlamJChoiAMHeme oxygenase-1/carbon monoxide: From basic science to therapeutic applicationsPhysiol Rev86583650200610.1152/physrev.00011.200516601269 RyterSWOtterbeinLEMorseDChoiAMHeme oxygenase/carbon monoxide signaling pathways: Regulation and functional significanceMol Cell Biochem 234–23512632002 WangXMKimHPNakahiraKRyterSWChoiAMThe heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1J Immunol18238093818200910.4049/jimmunol.071243719265160 ChhikaraMWangSKernSJFerreyraGABarbJJMunsonPJDannerRLCarbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-kappaB signal transduction in human monocytesPLoS One4e8139200910.1371/journal.pone.0008139199565412780718 NakaoSOgataYShimizu-SasakiEYamazakiMFuruyamaSSugiyaHActivation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblastsMol Cell Biochem209113118200010.1023/A:100715552502010942208 MorseDPischkeSEZhouZDavisRJFlavellRALoopTOtterbeinSLOtterbeinLEChoiAMSuppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1J Biol Chem2783699336998200310.1074/jbc.M30294220012857751 SaradyJKOtterbeinSLLiuFOtterbeinLEChoiAMCarbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophagesAm J Respir Cell Mol Biol27739745200210.1165/rcmb.481612444034 JangSIKimHJKimYJJeongSIYouYOTanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathwaysEur J Pharmacol54217200610.1016/j.ejphar.2006.04.04416797002 ChiuWTLinYLChouCWChenRMPropofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFkappaBChem Biol Interact181430439200910.1016/j.cbi.2009.06.01119573522 JawanBKaoYHGotoSPanMCLinYCHsuLWNakanoTLaiCYSunCKChengYFPropofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-kappaB translocationToxicol Appl Pharmacol229362373200810.1016/j.taap.2008.01.04418387647 ChenWCTsengCKChenYHLinCKHsuSHWangSNLeeJCHCV NS5A Up-regulates COX-2 expression via IL-8-mediated activation of the ERK/JNK MAPK pathwayPLoS One10e0133264201510.1371/journal.pone.0133264262310354521820 GuWSongLLiXMWangDGuoXJXuWGMesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathwaysSci Rep58733201510.1038/srep08733257364344348625

Effects of taurine on the levels of (A) AST and (B) ALT. Data are presented as the mean ± standard deviation (n=10). **P<0.01 vs. NS group and ##P<0.01 vs. LPS group. AST, aspartate transaminase; ALT, alanine transaminase; NS, normal saline group; LPS, lipopolysaccharide control group; TL, taurine + LPS group.

Effects of taurine on the levels of (A)SOD and (B) MDA. Data are presented as the mean ± standard deviation (n=10). **P<0.01 vs. NS group and ##P<0.01 vs. LPS group. SOD, superoxide dismutase; MDA, malonaldehyde; NS, normal saline group; LPS, lipopolysaccharide control group; TL, taurine + LPS group.

Effects of taurine on the levels of (A) IL-6, (B) TNF-α and (C) PCT. Data are presented as the mean ± standard deviation (n=10). *P<0.05 vs. NS group, **P<0.01 vs. NS group, #P<0.05 vs. LPS group and ##P<0.01 vs. LPS group. IL-6, interleukin 6; TNF-α, tumor necrosis factor-α; PCT, procalcitonin; NS, normal saline group; LPS, lipopolysaccharide control group; TL, taurine + LPS group.

Photomicrographs of hematoxylin and eosin staining in the liver tissue of each group. (A) NS group, (B) LPS group and (C) TL group. Scale bar, 100 µm. NS, normal saline group; LPS, lipopolysaccharide control group; TL, taurine + LPS group.

Effects of taurine on the expression levels of HO-1, COX-2, pNF-κB and p-ERK protein. Representative western blot images and quantification of (A) HO-1, (B) COX-2, (C) pNF-κB and (D) p-ERK. Data are presented as the mean ± standard deviation. **P<0.01 vs. NS group and ##P<0.01 vs. TL group; n=6 per group. HO-1, heme oxygenase-1; COX-2, cyclooxygenase-2; NF-κB, nuclear factor-κB; ERK, extracellular signal-regulated kinase; p-, phosphorylated.